Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents and antidepressants. Its stereochemistry and halogenated aromatic structure make it valuable for constructing active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Commonly employed in the preparation of serotonin and norepinephrine reuptake inhibitors (SNRIs), where the (R)-configuration enhances binding affinity and metabolic stability. Also utilized in research settings for asymmetric synthesis and development of novel fluorinated bioactive molecules.